vs
LIGHTPATH TECHNOLOGIES INC（LPTH）与礼来（RNA）财务数据对比。点击上方公司名可切换其他公司
LIGHTPATH TECHNOLOGIES INC的季度营收约是礼来的1.3倍（$16.4M vs $12.5M），LIGHTPATH TECHNOLOGIES INC净利率更高（-57.5% vs -1398.3%，领先1340.8%），礼来同比增速更快（434.0% vs 120.2%），LIGHTPATH TECHNOLOGIES INC自由现金流更多（$2.0M vs $-156.9M），过去两年礼来的营收复合增速更高（138.5% vs 45.7%）
LightPath Technologies Inc是一家精密光学组件及组件生产商，主营非球面透镜、红外光学器件、光纤产品等，服务工业自动化、航空航天、国防、医疗成像、电信等领域的全球客户，提供标准及定制化光学解决方案。
礼来是总部位于美国印第安纳州印第安纳波利斯的跨国制药企业，在18个国家设有办事处，产品销往全球约125个国家。公司由美国内战时期联邦军退伍军人、药剂师伊莱·礼来于1876年创立，品牌名即取自创始人姓名。
LPTH vs RNA — 直观对比
营收规模更大
LPTH
是对方的1.3倍
$12.5M
营收增速更快
RNA
高出313.8%
120.2%
净利率更高
LPTH
高出1340.8%
-1398.3%
自由现金流更多
LPTH
多$158.8M
$-156.9M
两年增速更快
RNA
近两年复合增速
45.7%
损益表 — Q2 FY2026 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.4M | $12.5M |
| 净利润 | $-9.4M | $-174.4M |
| 毛利率 | 36.8% | — |
| 营业利润率 | -52.6% | -1513.5% |
| 净利率 | -57.5% | -1398.3% |
| 营收同比 | 120.2% | 434.0% |
| 净利润同比 | -260.1% | -117.0% |
| 每股收益（稀释后） | $-0.20 | $-1.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LPTHRNA
| Q4 25 | $16.4M | — | ||
| Q3 25 | $15.1M | $12.5M | ||
| Q2 25 | $12.2M | $3.8M | ||
| Q1 25 | $9.2M | $1.6M | ||
| Q4 24 | $7.4M | $3.0M | ||
| Q3 24 | $8.4M | $2.3M | ||
| Q2 24 | $8.6M | $2.0M | ||
| Q1 24 | $7.7M | $3.5M |
净利润LPTHRNA
| Q4 25 | $-9.4M | — | ||
| Q3 25 | $-2.9M | $-174.4M | ||
| Q2 25 | $-7.1M | $-157.3M | ||
| Q1 25 | $-3.6M | $-115.8M | ||
| Q4 24 | $-2.6M | $-102.3M | ||
| Q3 24 | $-1.6M | $-80.4M | ||
| Q2 24 | $-2.4M | $-70.8M | ||
| Q1 24 | $-2.6M | $-68.9M |
毛利率LPTHRNA
| Q4 25 | 36.8% | — | ||
| Q3 25 | 29.8% | — | ||
| Q2 25 | 22.0% | — | ||
| Q1 25 | 29.1% | — | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 33.9% | — | ||
| Q2 24 | 29.2% | — | ||
| Q1 24 | 20.9% | — |
营业利润率LPTHRNA
| Q4 25 | -52.6% | — | ||
| Q3 25 | -16.6% | -1513.5% | ||
| Q2 25 | -38.0% | -4448.7% | ||
| Q1 25 | -36.3% | -8360.9% | ||
| Q4 24 | -33.5% | -4069.6% | ||
| Q3 24 | -16.4% | -4200.9% | ||
| Q2 24 | -25.6% | -4040.4% | ||
| Q1 24 | -33.6% | -2178.6% |
净利率LPTHRNA
| Q4 25 | -57.5% | — | ||
| Q3 25 | -19.2% | -1398.3% | ||
| Q2 25 | -57.8% | -4089.3% | ||
| Q1 25 | -39.1% | -7360.0% | ||
| Q4 24 | -35.2% | -3439.5% | ||
| Q3 24 | -19.3% | -3441.7% | ||
| Q2 24 | -27.3% | -3461.8% | ||
| Q1 24 | -33.7% | -1943.4% |
每股收益（稀释后）LPTHRNA
| Q4 25 | $-0.20 | — | ||
| Q3 25 | $-0.07 | $-1.27 | ||
| Q2 25 | $0.19 | $-1.21 | ||
| Q1 25 | $-0.44 | $-0.90 | ||
| Q4 24 | $-0.07 | $-0.80 | ||
| Q3 24 | $-0.04 | $-0.65 | ||
| Q2 24 | $-0.15 | $-0.65 | ||
| Q1 24 | $-0.07 | $-0.79 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $73.6M | $350.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $77.9M | $1.9B |
| 总资产 | $148.6M | $2.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LPTHRNA
| Q4 25 | $73.6M | — | ||
| Q3 25 | — | $350.2M | ||
| Q2 25 | $4.9M | $243.9M | ||
| Q1 25 | — | $254.2M | ||
| Q4 24 | — | $219.9M | ||
| Q3 24 | — | $370.2M | ||
| Q2 24 | — | $575.8M | ||
| Q1 24 | — | $471.4M |
总债务LPTHRNA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $535.0K | — | ||
| Q1 24 | $599.4K | — |
股东权益LPTHRNA
| Q4 25 | $77.9M | — | ||
| Q3 25 | $21.4M | $1.9B | ||
| Q2 25 | $15.6M | $1.2B | ||
| Q1 25 | $15.7M | $1.3B | ||
| Q4 24 | $26.7M | $1.4B | ||
| Q3 24 | $29.4M | $1.5B | ||
| Q2 24 | $30.2M | $1.2B | ||
| Q1 24 | $31.7M | $830.9M |
总资产LPTHRNA
| Q4 25 | $148.6M | — | ||
| Q3 25 | $87.3M | $2.1B | ||
| Q2 25 | $81.5M | $1.4B | ||
| Q1 25 | $81.4M | $1.5B | ||
| Q4 24 | $45.8M | $1.6B | ||
| Q3 24 | $48.4M | $1.6B | ||
| Q2 24 | $48.1M | $1.3B | ||
| Q1 24 | $49.7M | $951.5M |
负债/权益比LPTHRNA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.02× | — | ||
| Q1 24 | 0.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.8M | $-156.2M |
| 自由现金流经营现金流 - 资本支出 | $2.0M | $-156.9M |
| 自由现金流率自由现金流/营收 | 12.0% | -1257.6% |
| 资本支出强度资本支出/营收 | 5.3% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-6.3M | $-592.3M |
8季度趋势，按日历期对齐
经营现金流LPTHRNA
| Q4 25 | $2.8M | — | ||
| Q3 25 | $-1.1M | $-156.2M | ||
| Q2 25 | $-2.6M | $-199.7M | ||
| Q1 25 | $-3.2M | $-124.8M | ||
| Q4 24 | $-737.4K | $-99.9M | ||
| Q3 24 | $-1.7M | $-65.6M | ||
| Q2 24 | $64.7K | $-65.0M | ||
| Q1 24 | $-394.2K | $-70.4M |
自由现金流LPTHRNA
| Q4 25 | $2.0M | — | ||
| Q3 25 | $-1.2M | $-156.9M | ||
| Q2 25 | $-3.3M | $-203.0M | ||
| Q1 25 | $-3.7M | $-128.6M | ||
| Q4 24 | $-817.8K | $-103.8M | ||
| Q3 24 | $-1.8M | $-67.3M | ||
| Q2 24 | $-225.5K | $-65.5M | ||
| Q1 24 | $-802.5K | $-71.3M |
自由现金流率LPTHRNA
| Q4 25 | 12.0% | — | ||
| Q3 25 | -8.1% | -1257.6% | ||
| Q2 25 | -27.3% | -5277.1% | ||
| Q1 25 | -40.0% | -8174.3% | ||
| Q4 24 | -11.0% | -3491.0% | ||
| Q3 24 | -21.2% | -2881.8% | ||
| Q2 24 | -2.6% | -3204.6% | ||
| Q1 24 | -10.4% | -2012.3% |
资本支出强度LPTHRNA
| Q4 25 | 5.3% | — | ||
| Q3 25 | 0.5% | 5.7% | ||
| Q2 25 | 5.6% | 86.9% | ||
| Q1 25 | 4.6% | 238.6% | ||
| Q4 24 | 1.1% | 131.7% | ||
| Q3 24 | 0.9% | 72.9% | ||
| Q2 24 | 3.4% | 26.0% | ||
| Q1 24 | 5.3% | 25.8% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LPTH
| Other | $7.9M | 48% |
| Infrared Components | $5.0M | 31% |
| Visible Components | $3.4M | 21% |
RNA
暂无分部数据
